AIM ImmunoTech, Inc. (AIM)

1.21 -0.08 (-6.20%) USD  |  NYAM  |  Jan 12, 10:30
More

AIM ImmunoTech Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
Agenus, Inc. Upgrade
Curis, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade